Literature DB >> 17120248

Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation.

An C Jansen1, Ozgur Sancak, Maria Daniela D'Agostino, AmanPreet Badhwar, Penelope Roberts, Gabriella Gobbi, Ralph Wilkinson, Denis Melanson, Donatella Tampieri, Robert Koenekoop, Mark Gans, Anneke Maat-Kievit, Miriam Goedbloed, Ans M W van den Ouweland, Mark Nellist, Massimo Pandolfo, Mary McQueen, Katherine Sims, Elisabeth A Thiele, François Dubeau, Frederick Andermann, David J Kwiatkowski, Dicky J J Halley, Eva Andermann.   

Abstract

OBJECTIVE: To report the clinical manifestations and functional aspects of Tuberous Sclerosis Complex (TSC), resulting from Codon 905 mutations in TSC2 gene.
METHODS: We performed a detailed study of the TSC phenotype and genotype in a large French-Canadian kindred (Family A). Subsequently, clinical and molecular data on 18 additional TSC families with missense mutations at the same codon of TSC2 were collected. Functional studies were performed on the different missense changes and related to the phenotype.
RESULTS: A 2714G>A (R905Q) mutation was identified in Family A. The TSC phenotype in this family was unusually mild and characterized by hypomelanotic macules or focal seizures that remitted spontaneously or were easily controlled with medication. Diagnostic criteria were met in only a minority of mutation carriers. Other families with the R905Q mutation were found to have a similar mild phenotype. In contrast, patients with a 2713C>T (R905W) or a 2713C>G (R905G) mutation had more severe phenotypes. Although all three amino acid substitutions were pathogenic, the R905W and R905G substitutions affected tuberin function more severely than R905Q.
INTERPRETATION: Codon 905 missense mutations in TSC2 are relatively common. The TSC2 R905Q mutation is associated with unusually mild disease, consistent with functional studies. Combined with previous reports, it is apparent that certain TSC2 missense mutations are associated with a mild form of tuberous sclerosis, which in many patients does not meet standard diagnostic criteria. These findings have implications for the large number of patients with limited clinical features of TSC and for genetic counseling in these families.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17120248     DOI: 10.1002/ana.21037

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  35 in total

1.  CT of sclerotic bone lesions: imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis.

Authors:  Nilo A Avila; Andrew J Dwyer; Antoinette Rabel; Thomas Darling; Chien-Hui Hong; Joel Moss
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

Review 2.  Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges.

Authors:  Romina Moavero; Caterina Cerminara; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2010-04-01       Impact factor: 1.475

3.  Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.

Authors:  Itzamarie Chévere-Torres; Jordan M Maki; Emanuela Santini; Eric Klann
Journal:  Neurobiol Dis       Date:  2011-07-30       Impact factor: 5.996

Review 4.  Potential for treatment of severe autism in tuberous sclerosis complex.

Authors:  Tanjala T Gipson; Gwendolyn Gerner; Mary Ann Wilson; Mary E Blue; Michael V Johnston
Journal:  World J Clin Pediatr       Date:  2013-08-08

5.  Evidence for population variation in TSC1 and TSC2 gene expression.

Authors:  Garilyn M Jentarra; Stephen G Rice; Shannon Olfers; David Saffen; Vinodh Narayanan
Journal:  BMC Med Genet       Date:  2011-02-23       Impact factor: 2.103

Review 6.  Hereditary genodermatoses with cancer predisposition.

Authors:  Meg R Gerstenblith; Alisa M Goldstein; Margaret A Tucker
Journal:  Hematol Oncol Clin North Am       Date:  2010-10       Impact factor: 3.722

7.  Genotype and cognitive phenotype of patients with tuberous sclerosis complex.

Authors:  Agnies M van Eeghen; Margaux E Black; Margaret B Pulsifer; David J Kwiatkowski; Elizabeth A Thiele
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

8.  A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.

Authors:  Magdalena E Tyburczy; Sergiusz Jozwiak; Izabela A Malinowska; Yvonne Chekaluk; Trevor J Pugh; Chin-Lee Wu; Robert L Nussbaum; Sara Seepo; Tomasz Dzik; Katarzyna Kotulska; David J Kwiatkowski
Journal:  Hum Mol Genet       Date:  2014-11-28       Impact factor: 6.150

9.  A reliable cell-based assay for testing unclassified TSC2 gene variants.

Authors:  Ricardo Coevoets; Sermin Arican; Marianne Hoogeveen-Westerveld; Erik Simons; Ans van den Ouweland; Dicky Halley; Mark Nellist
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

10.  A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles.

Authors:  Kristen Pollizzi; Izabela Malinowska-Kolodziej; Cheryl Doughty; Charles Betz; Jian Ma; June Goto; David J Kwiatkowski
Journal:  Hum Mol Genet       Date:  2009-04-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.